Tirzepatide for Obesity Treatment and Diabetes Prevention
New England Journal of Medicine · 06.03.2025 · 392 (10) · 958-971
DOI: 10.1056/nejmoa2410819 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 06.03.2025. Verfasst von Ania M Jastreboff und 13 weiteren Autor:innen. Beteiligte Einrichtung: Y-Weight Yale Obesity Research Center, Section of Endocrinology and Metabolism, Department of Medicine, Yale School of Medicine, New Haven, CT. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Obesity, Prediabetic State, Tirzepatide. Die Arbeit wurde bisher 475-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Eli Lilly and Company.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Y-Weight Yale Obesity Research Center, Section of Endocrinology and Metabolism, Department of Medicine, Yale School of Medicine, New Haven, CT.
- Section of Pediatric Endocrinology, Department of Pediatrics, Yale School of Medicine, New Haven, CT.
- Diabetes Complications Research Centre, University College Dublin, Dublin.
- Eli Lilly, Indianapolis.
- Comprehensive Weight Control Center, Division of Endocrinology, Diabetes, and Metabolism, Weill Cornell Medicine, New York.
- Hospital 9 de Julho, São Paulo.
ORCID-Profile: Ania M Jastreboff, Bruno Halpern
Förderung
- Eli Lilly and Company
Zitieren
APA
Jastreboff, A. M., le Roux, C. W., Stefanski, A., Aronne, L. J., Halpern, B., Wharton, S., Wilding, J. P. H., Perreault, L., Zhang, S., Battula, R., Bunck, M. C., Ahmad, N. N., Jouravskaya, I., & SURMOUNT-1 Investigators (2025). Tirzepatide for Obesity Treatment and Diabetes Prevention. New England Journal of Medicine, 392(10), 958-971. https://doi.org/10.1056/nejmoa2410819
Vancouver
Jastreboff AM, le Roux CW, Stefanski A, Aronne LJ, Halpern B, Wharton S, et al. Tirzepatide for Obesity Treatment and Diabetes Prevention. New England Journal of Medicine. 2025;392(10):958-971. doi:10.1056/nejmoa2410819
BibTeX
@article{Jastreboff2025,
author = {Jastreboff, Ania M and le Roux, Carel W and Stefanski, Adam and Aronne, Louis J and Halpern, Bruno and Wharton, Sean and Wilding, John P H and Perreault, Leigh and Zhang, Shuyu and Battula, Ramakrishna and Bunck, Mathijs C and Ahmad, Nadia N and Jouravskaya, Irina and SURMOUNT-1 Investigators, SURMOUNT-1 Investigators},
title = {Tirzepatide for Obesity Treatment and Diabetes Prevention},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {10},
pages = {958--971},
doi = {10.1056/nejmoa2410819}
}
EUVIMED